FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2614881333> ?p ?o ?g. }

• W2614881333 abstract "Background: Aβ pathology is associated with longitudinal changes of brain metabolism, atrophy, and cognition, in cognitively healthy elders. However, Aβ information is usually measured cross-sectionally and dichotomized to classify subjects as Aβ-positive or Aβ-negative, making it difficult to evaluate when brain and cognitive changes occur with respect to emerging Aβ pathology. In this study, we use longitudinal Aβ information to combine the level and rate of change of Aβ to estimate the time to Aβ-positivity for each subject and test this temporal proximity to significant Aβ pathology for associations with brain structure, metabolism, and cognition. Methods: In 89 cognitively healthy elders with up to 10 years of follow-up, we estimated the points at which rates of fluorodeoxyglucose (FDG) PET, MRI, and cognitive and functional decline begin to accelerate with respect to the time to Aβ-positivity. Points of initial acceleration in rates of decline were estimated using mixed-effects models with penalized regression splines. Results: Acceleration of rates of FDG PET were observed to occur 20+ years before the conventional threshold for Aβ-positivity. Subtle signs of cognitive dysfunction were observed 10+ years before Aβ-positivity. Conclusions: Aβ may have subtle associations with other hallmarks of Alzheimer's disease before Aβ biomarkers reach conventional thresholds for Aβ-positivity. Therefore, we propose that emerging Aβ pathology occurs many years before cognitively healthy elders reach the current threshold for Aβ positivity (preclinical AD). To allow prevention in the earliest disease stages, AD clinical trials may be designed to also include subjects with Aβ biomarkers in the sub-threshold range." @default.
• W2614881333 created "2017-05-26" @default.
• W2614881333 creator A5024110469 @default.
• W2614881333 creator A5035352293 @default.
• W2614881333 creator A5043086041 @default.
• W2614881333 creator A5045343267 @default.
• W2614881333 creator A5049277633 @default.
• W2614881333 creator A5053131013 @default.
• W2614881333 creator A5055720552 @default.
• W2614881333 creator A5061269385 @default.
• W2614881333 creator A5086120667 @default.
• W2614881333 date "2017-05-17" @default.
• W2614881333 modified "2023-10-16" @default.
• W2614881333 title "Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease" @default.
• W2614881333 cites W1953027527 @default.
• W2614881333 cites W1975727000 @default.
• W2614881333 cites W1987777001 @default.
• W2614881333 cites W1991952617 @default.
• W2614881333 cites W2004293194 @default.
• W2614881333 cites W2008301592 @default.
• W2614881333 cites W2025983435 @default.
• W2614881333 cites W2030847210 @default.
• W2614881333 cites W2037213523 @default.
• W2614881333 cites W2044005042 @default.
• W2614881333 cites W2044614452 @default.
• W2614881333 cites W2052742260 @default.
• W2614881333 cites W2078524519 @default.
• W2614881333 cites W2079540265 @default.
• W2614881333 cites W2082429191 @default.
• W2614881333 cites W2085558649 @default.
• W2614881333 cites W2085870059 @default.
• W2614881333 cites W2096063777 @default.
• W2614881333 cites W2096410114 @default.
• W2614881333 cites W2103861278 @default.
• W2614881333 cites W2112579276 @default.
• W2614881333 cites W2115017507 @default.
• W2614881333 cites W2116886795 @default.
• W2614881333 cites W2134711807 @default.
• W2614881333 cites W2144138616 @default.
• W2614881333 cites W2148080316 @default.
• W2614881333 cites W2148943235 @default.
• W2614881333 cites W2153645950 @default.
• W2614881333 cites W2155277084 @default.
• W2614881333 cites W2157657208 @default.
• W2614881333 cites W2160597466 @default.
• W2614881333 cites W2167720733 @default.
• W2614881333 cites W2168357345 @default.
• W2614881333 cites W2215958284 @default.
• W2614881333 cites W2290598353 @default.
• W2614881333 cites W2302528231 @default.
• W2614881333 cites W2341604488 @default.
• W2614881333 cites W2463439240 @default.
• W2614881333 cites W2480170620 @default.
• W2614881333 cites W4254818805 @default.
• W2614881333 doi "https://doi.org/10.3389/fnins.2017.00281" @default.
• W2614881333 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5434146" @default.
• W2614881333 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28567001" @default.
• W2614881333 hasPublicationYear "2017" @default.
• W2614881333 type Work @default.
• W2614881333 sameAs 2614881333 @default.
• W2614881333 citedByCount "58" @default.
• W2614881333 countsByYear W26148813332017 @default.
• W2614881333 countsByYear W26148813332018 @default.
• W2614881333 countsByYear W26148813332019 @default.
• W2614881333 countsByYear W26148813332020 @default.
• W2614881333 countsByYear W26148813332021 @default.
• W2614881333 countsByYear W26148813332022 @default.
• W2614881333 countsByYear W26148813332023 @default.
• W2614881333 crossrefType "journal-article" @default.
• W2614881333 hasAuthorship W2614881333A5024110469 @default.
• W2614881333 hasAuthorship W2614881333A5035352293 @default.
• W2614881333 hasAuthorship W2614881333A5043086041 @default.
• W2614881333 hasAuthorship W2614881333A5045343267 @default.
• W2614881333 hasAuthorship W2614881333A5049277633 @default.
• W2614881333 hasAuthorship W2614881333A5053131013 @default.
• W2614881333 hasAuthorship W2614881333A5055720552 @default.
• W2614881333 hasAuthorship W2614881333A5061269385 @default.
• W2614881333 hasAuthorship W2614881333A5086120667 @default.
• W2614881333 hasBestOaLocation W26148813331 @default.
• W2614881333 hasConcept C142724271 @default.
• W2614881333 hasConcept C15744967 @default.
• W2614881333 hasConcept C169760540 @default.
• W2614881333 hasConcept C169900460 @default.
• W2614881333 hasConcept C2779134260 @default.
• W2614881333 hasConcept C2779483572 @default.
• W2614881333 hasConcept C2781172350 @default.
• W2614881333 hasConcept C2984863031 @default.
• W2614881333 hasConcept C502032728 @default.
• W2614881333 hasConcept C58693492 @default.
• W2614881333 hasConcept C71924100 @default.
• W2614881333 hasConceptScore W2614881333C142724271 @default.
• W2614881333 hasConceptScore W2614881333C15744967 @default.
• W2614881333 hasConceptScore W2614881333C169760540 @default.
• W2614881333 hasConceptScore W2614881333C169900460 @default.
• W2614881333 hasConceptScore W2614881333C2779134260 @default.
• W2614881333 hasConceptScore W2614881333C2779483572 @default.
• W2614881333 hasConceptScore W2614881333C2781172350 @default.
• W2614881333 hasConceptScore W2614881333C2984863031 @default.
• W2614881333 hasConceptScore W2614881333C502032728 @default.
• W2614881333 hasConceptScore W2614881333C58693492 @default.

• next